The recipients of the Sophion research grant are utilizing the grant to conduct research on chemotherapy drugs affecting Nav1.7 currents, further deepening their studies on sodium channels and cancer by using Sophion's automated patch clamp system. They are an assistant professor at Istanbul Medipol University and are currently affiliated with our laboratory in Copenhagen, conducting research alongside senior researcher Kim Boddum. We had a discussion about the research and its objectives. For more details, please refer to the related links.

Our company is jointly developing a new protocol that enables efficient screening studies to identify modulators of Kv7.2/Kv7.3 channel activity using spider venom peptides. This will advance the understanding of gain-of-function mutations in channel-related epilepsy and potential therapies. For more details, please see the related links.